CN100534496C - Chinese medicine for treating ischemic necrosis of femoral head - Google Patents

Chinese medicine for treating ischemic necrosis of femoral head Download PDF

Info

Publication number
CN100534496C
CN100534496C CNB2006101349617A CN200610134961A CN100534496C CN 100534496 C CN100534496 C CN 100534496C CN B2006101349617 A CNB2006101349617 A CN B2006101349617A CN 200610134961 A CN200610134961 A CN 200610134961A CN 100534496 C CN100534496 C CN 100534496C
Authority
CN
China
Prior art keywords
radix
chinese medicine
femoral head
treatment
root
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB2006101349617A
Other languages
Chinese (zh)
Other versions
CN1994428A (en
Inventor
阎贵坤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNB2006101349617A priority Critical patent/CN100534496C/en
Publication of CN1994428A publication Critical patent/CN1994428A/en
Application granted granted Critical
Publication of CN100534496C publication Critical patent/CN100534496C/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

Disclosed is a Chinese medicament for treating necrosis of femoral head which is prepared from the following constituents (by weight proportions): red ginseng 2-3g, Chinese angelica root 5-8g, saffron 5-10g, root of red rooted saliva 5-10g, dragon's blood resin 5-8g, dried rehmannia root 5-10g, eucommia bark 5-7g, prepared rhizome of rehmannia 5-10g, bupleurum root 5-10g, Siberian solomonseal rhizome 5-10g, frankincense 5-10g, myrrh 5-10g, rhubarb horsetails 3-5g, schisandra fruit 5-10g, musk 1g, borneol 5-7g, agkistrodon acutus 2-3g. The medicament can be prepared into capsules, powders and decoctions.

Description

A kind of Chinese medicine for the treatment of ischemia femur head necrosis
Technical field
The invention belongs to Chinese medicine, a kind of Chinese medicine for the treatment of ischemia femur head necrosis of saying so more accurately.
Background technology
Ischemia femur head necrosis is a kind of because reasons such as wound, rheumatism, cause blood supply insufficiency and cause the disease of femoral head pathological change, main disease shows as pain, difficulty in walking, patients whose symptoms were less severe and loses viability, and the heavier person's deformity of symptom be can't take care of oneself.At present doctor trained in Western medicine mainly adopts and changes the femoral head treatment, can relief of symptoms, but service time is limited.The traditional Chinese medical science also has the Chinese medicine of various treatment femur head necrosiss, the therapeutic effect difference.
Summary of the invention
Given this, the object of the present invention is to provide a kind of Chinese medicine that can effectively control ischemia femur head necrosis.
Purpose of the present invention is achieved through the following technical solutions: a kind of Chinese medicine for the treatment of ischemia femur head necrosis, form by the Chinese medicine of following prescription:
Radix Ginseng Rubra 2-3g Radix Angelicae Sinensis 5-8g Stigma Croci 5-10g
Radix Salviae Miltiorrhizae 5-10g Sanguis Draxonis 5-8g Radix Rehmanniae 5g-10g
Cortex Eucommiae 5-7g Radix Rehmanniae Preparata 5-10g Radix Bupleuri 5-10g
Rhizoma Polygonati 5-10g Olibanum 5-10g Myrrha 5-10g
Radix Et Rhizoma Rhei 3-5g Fructus Schisandrae Chinensis 5-10g Moschus 1g
Borneolum Syntheticum 5-7g Agkistrodon 2-3g
By the Chinese medicine of above-mentioned prescription,, produce capsule, diffusing, decoction by conventional Chinese medicine processing technique.
48 years old Liao-Shen Evening workman of Shenyang City of case 1. Gong Jun booths man
Medical history 3 years, skelalgia, difficulty in walking.Through Shenyang orthopaedics hospital diagnosis: the right side ischemic necrosis of femoral head.
Clinically take decoction of the present invention, day clothes 2 times were taken medicine 60, and sx was taken medicine 180, and recovery from illness was followed up a case by regular visits to 2 years, recurrence.
Neat expensive multiple man Yi Matu township, Fuxin county Qing Duizi people from village of the 50 years old Liaoning Province medical histories of case 2. 6 years because of suffering from rheumatism, are often taken hormone medicine, cause the bilateral femoral head ischemic necrosis, clinical diagnosis: bilateral femoral head ischemic necrosis late period.
Take capsule of the present invention, sx after 60 days generates new bone after seven months, the bone trabecula marshalling, and bone density is even, calms down recovery from illness, follows up a case by regular visits to and does not recur in 8 years
Case 3: Wang Yu literary composition man people from Zhangwu County of 44 years old Liaoning Province
Medical history 2 years, excessive because of hyperpyrexia injection dexamethasone, suffer from the bilateral femoral head ischemic necrosis, clinically take capsule of the present invention recovery from illness in 6 months.
The Chinese medicine of treatment ischemic necrosis of femoral head of the present invention, invigorating the liver and kidney, benefiting essence-blood, blood circulation promoting and blood stasis dispelling recovers refreshing smart, and hemopoietic is active, and bone marrow has life, has the function for the treatment of both the principal and secondary aspects of a disease, determined curative effect, effect is remarkable.
The specific embodiment
A kind of Chinese medicine for the treatment of ischemic necrosis of femoral head is made up of the Chinese medicine of following prescription:
Get:
Radix Ginseng Rubra 3g Radix Angelicae Sinensis 6g Stigma Croci 8g
Radix Salviae Miltiorrhizae 10g Sanguis Draxonis 5g Radix Rehmanniae 10g
Cortex Eucommiae 5g Radix Rehmanniae Preparata 10g Radix Bupleuri 10g
Rhizoma Polygonati 8g Olibanum 8g Myrrha 10g
Radix Et Rhizoma Rhei 3g Fructus Schisandrae Chinensis 10g Moschus 1g
Borneolum Syntheticum 5g Agkistrodon 2g
By the Chinese medicine of above-mentioned prescription,, produce capsule by conventional Chinese medicine processing technique.
Adopt above-mentioned capsule for treating ischemic necrosis of fermoral head 34 routine clinical sights to look into report
Key word: ischemic necrosis of femoral head Chinese medicinal capsule
Summary: purpose: the Chinese medicine clinical therapeutic efficacy of understanding the treatment ischemic necrosis of femoral head
Method: adopt the stochastic sampling double-blind method, observe therapeutic effect and the safety thereof of capsule to 34 routine ischemic necrosis of femoral head patients.
Do not find any side effect in clinical.
Conclusion: determined curative effect, safe and practical.
1. materials and methods
Resemble 1.1 see to check
Take ischemic necrosis of femoral head capsule Chinese medicine patient 34 examples the same period, age 28-57 year.
1.2 therapeutic regimen
Full group patient is divided into treatment at random by double-blind method and organizes 34 examples.The treatment group gives capsule oral medicinal herb treatment, 1 twice-daily, early, dinner takes after half an hour.
1.3 sight checking method
Before treating, the each patient all writes down medical history, sign, and relevant physics, physiology inspection.
1.4 therapeutic effect is seen and is looked into
The patient 30 days was a course of treatment with medication, and the treatment phase is 6-8 the course of treatment.
Criterion of therapeutical effect:
A is invalid: the treatment back does not have change with the preceding state of an illness symptom of treatment.
B is effective: treatment back state of an illness sign has improvement.
The C produce effects: treatment back state of an illness sign has clear improvement.
The D recovery from illness: treatment back disease all disappears, and reaches the clinical cure standard.
Treatment is analyzed
All clinical datas are judged comparison with the treatment group in invalid, effective, produce effects, four standards of recovery from illness behind finishing analysis, by statistical procedures, see the significance of looking into its difference,
2. result
The 2-1 curative effect
This group 34 examples are used decoction treatment by Chinese herbs myasthenia gravis patient efficacy result
Figure C20061013496100051
34 routine patient treatment curative effect statistical tables
Figure C20061013496100062
Statistical procedures
P<0.01
2.2 toxic and side effects
Toxic and side effects such as discomfort appear in 34 none example of example treatment patient.Test check blood, urine, the just all no abnormal change of routine, liver, renal function.Point out capsule safety of the present invention thus, without any side effects.

Claims (1)

1, a kind of Chinese medicine of smelting treatment ischemia femur head necrosis, it is characterized in that: this medicament is made by following herbal raw material:
Radix Ginseng Rubra 2-3g Radix Angelicae Sinensis 5-8g Stigma Croci 5-10g
Radix Salviae Miltiorrhizae 5-10g Sanguis Draxonis 5-8g Radix Rehmanniae 5-10g
Cortex Eucommiae 5-7g Radix Rehmanniae Preparata 5-10g Radix Bupleuri 5-10g
Rhizoma Polygonati 5-10g Olibanum 5-10g Myrrha 5-10g
Radix Et Rhizoma Rhei 3-5g Fructus Schisandrae Chinensis 5-10g Moschus 1g
Borneolum Syntheticum 5-7g Agkistrodon 2-3g
Its manufacture method is: the Chinese medicine processing technique is produced capsule, diffusing, decoction routinely.
CNB2006101349617A 2006-12-22 2006-12-22 Chinese medicine for treating ischemic necrosis of femoral head Expired - Fee Related CN100534496C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB2006101349617A CN100534496C (en) 2006-12-22 2006-12-22 Chinese medicine for treating ischemic necrosis of femoral head

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB2006101349617A CN100534496C (en) 2006-12-22 2006-12-22 Chinese medicine for treating ischemic necrosis of femoral head

Publications (2)

Publication Number Publication Date
CN1994428A CN1994428A (en) 2007-07-11
CN100534496C true CN100534496C (en) 2009-09-02

Family

ID=38249684

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB2006101349617A Expired - Fee Related CN100534496C (en) 2006-12-22 2006-12-22 Chinese medicine for treating ischemic necrosis of femoral head

Country Status (1)

Country Link
CN (1) CN100534496C (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104435715A (en) * 2014-12-22 2015-03-25 徐晓辉 Traditional Chinese medicinal liquid for treating avascular necrosis of femoral head
CN104825704A (en) * 2015-05-22 2015-08-12 青岛市市立医院 Traditional Chinese medicine composition for treating femoral head necrosis

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
中医药治疗股骨头坏死概况. 吴建华,刘滋雷,尹斌文.中国中医骨伤科,第2期. 1994
中医药治疗股骨头坏死概况. 吴建华,刘滋雷,尹斌文.中国中医骨伤科,第2期. 1994 *

Also Published As

Publication number Publication date
CN1994428A (en) 2007-07-11

Similar Documents

Publication Publication Date Title
CN102614440B (en) Multi-herb antibacterial liquid
CN102512611B (en) Traditional Chinese medicine for treating recurrent oral ulcer and preparation method
CN100376229C (en) A medicinal wine for treating rheumatic and rheumatoid disease
CN103356877A (en) Traditional Chinese medicine composition for treating orthopedic diseases
CN114377062B (en) Traditional Chinese medicine composition for treating liver and kidney deficiency type bone arthralgia, preparation and application
CN103330806A (en) Drug for treatment of rheumatoid arthritis
CN105169076A (en) Traditional Chinese medicine composition for treating irregular menstruation
CN104873898A (en) Preparation, namely blood conducting powder containing kudzuvine root and safflower, for treating hemiplegia
CN102688387B (en) Medicine for treating subacute thyroiditis
CN100534496C (en) Chinese medicine for treating ischemic necrosis of femoral head
CN103301326A (en) Medicament for treating rheumatism, rheumatoid and pain or rheumatism in lower extremities and waist
CN103393999A (en) Anti-inflammatory resolutive liquid medicine for promoting blood circulation to arrest pain
CN103356925B (en) Traditional Chinese medicine composition for treating sperm non-liquified symptom
CN100493590C (en) Astragalus leech collateral clearing capsule
CN101912540A (en) Medicament for treating cerebral infarction
CN101856455B (en) Chinese medicament for treating psoriasis vulgaris
CN102406870B (en) Medicament for treating rheumatic arthralgia
CN101411799B (en) Oral medicinal liquor for treating rheumatism and rheumatoid disease
CN102302578A (en) Medicament capable of eliminating dampness and relieving numbness and preparation method thereof
CN105311140A (en) Pharmaceutical composition for treating cervical spondylosis and preparation method thereof
CN103341100A (en) Medicinal liquor for activating blood, relieving pain, resisting inflammation and diminishing swelling
CN103721188B (en) A kind of injection care drug preventing cerebrovascular sclerosis and preparation method thereof
CN102293836A (en) Chinese patent drug for treating swollen pains and numb of waist and legs and functional disorder and preparation method
CN101062340A (en) Chinese traditional medicine combination good for liver for revovery
CN101979073A (en) Medicament for soothing liver and regulating Qi

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20090902

Termination date: 20101222